SCHEMBL173379

SCHEMBL173379

C1CCCCCCCCCCCCCCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclooctane SCHEMBL11038481 1.00 ALDH1A1 (0.33) ALDH1A1
SCHEMBL13468315 1.00 ALDH1A1 (0.33) ALDH1A1
SCHEMBL2761107 1.00 ALDH1A1 (0.33) ALDH1A1
SCHEMBL25378505 1.00 ALDH1A1 (0.33) ALDH1A1
SCHEMBL1542881 1.00 ALDH1A1 (0.33) ALDH1A1
Cyclohexane SCHEMBL23142614 1.00 ALDH1A1 (0.33) ALDH1A1
SCHEMBL161597 1.00 ALDH1A1 (0.33) ALDH1A1
Cyclooctane SCHEMBL31262 1.00
Cyclohexane SCHEMBL2291099 1.00
SCHEMBL286862 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250062407-A1 ORGANIC ELECTROLYTE, AND SECONDARY BATTERY COMPRISING SAME SAMSUNG SDI CO., LTD. (KR) 2025-02-20 US claimed
CN-119486546-A Thin film, photoelectric device, display device and preparation method 广东聚华印刷显示技术有限公司 2025-02-18 CN claimed
US-12176484-B2 Organic electrolyte, and secondary battery comprising same SAMSUNG SDI CO., LTD. (KR) 2024-12-24 US claimed
US-20220093970-A1 ORGANIC ELECTROLYTE, AND SECONDARY BATTERY COMPRISING SAME SAMSUNG SDI CO., LTD. (KR) 2022-03-24 US claimed
CN-107003566-B Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element 日产化学工业株式会社 2020-12-04 CN claimed
US-9115249-B2 Method for the production of hydrogen from the dehydrocoupling of amine boranes KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2015-08-25 US claimed
US-20110104046-A1 METHOD FOR THE PRODUCTION OF HYDROGEN FROM THE DEHYDROCOUPLING OF AMINE BORANES KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2011-05-05 US claimed
WO-2009137932-A1 METHOD FOR THE PRODUCTION OF HYDROGEN FROM THE DEHYDROCOUPLING OF AMINE BORANES KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2009-11-19 WO claimed
US-4152358-A FROM ALIPHATIC, AROMATIC OR ALICYCLIC HYDROCARBON IN PRESENCE OF PHOSPHATE OF URANIUM, COPPER OR IRON PETRO-TEX CHEMICAL CORPORATION (US) 1979-05-01 US claimed
EP-3719880-B1 LITHIUM ION BATTERY PANASONIC IP MAN CO LTD (JP) 2026-04-29 EP disclosed
US-20260001983-A1 CATION EXCHANGE RESIN, CATION EXCHANGE MEMBRANE, ELECTROLYTE MEMBRANE, BINDER FOR FORMING ELECTRODE CATALYST LAYER, AND BATTERY ELECTRODE CATALYST LAYER UNIVERSITY OF YAMANASHI (JP) 2026-01-01 US disclosed
US-20250353950-A1 ANION EXCHANGE RESIN, ELECTROLYTE MEMBRANE, BINDER FOR FORMING ELECTRODE CATALYST LAYER, AND BATTERY ELECTRODE CATALYST LAYER UNIVERSITY OF YAMANASHI (JP) 2025-11-20 US disclosed
US-12458705-B2 Antibody-oligonucleotide conjugates ANGIEX, INC. (US) 2025-11-04 US disclosed
US-12428477-B2 Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same ANGIEX, INC. (US) 2025-09-30 US disclosed
EP-0005527-A2 Process for the preparation of substituted norbornene derivatives and norbornene derivatives The B.F. GOODRICH Company (US) 1979-11-28 EP disclosed
EP-0004611-A1 Process for the preparation of acetoacetylaryl amides CIBA-GEIGY AG (CH) 1979-10-17 EP disclosed
US-4152358-A FROM ALIPHATIC, AROMATIC OR ALICYCLIC HYDROCARBON IN PRESENCE OF PHOSPHATE OF URANIUM, COPPER OR IRON PETRO-TEX CHEMICAL CORPORATION (US) 1979-05-01 US disclosed
US-4098817-A OXIDATION OF CYCLOALIPHATIC COMPOUNDS PETRO-TEX CHEMICAL CORPORATION (US) 1978-07-04 US disclosed
US-3974228-A BUFFERS PETRO-TEX CHEMICAL CORPORATION (US) 1976-08-10 US disclosed
US-3960897-A PEROXIDE RESEARCH CORPORATION (US) 1976-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12428477-B2 Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same TM9SF4, TM9SF2, TM9SF3 ALDH1A1 2725/4885
US-20260001983-A1 CATION EXCHANGE RESIN, CATION EXCHANGE MEMBRANE, ELECTROLYTE MEMBRANE, BINDER FOR FORMING ELECTRODE CATALYST LAYER, AND BATTERY ELECTRODE CATALYST LAYER SLC9A1, SLC9A2, SLC9A3 ALDH1A1 3368/4885
US-12458705-B2 Antibody-oligonucleotide conjugates TM9SF4, TMSB4X, IGSF11 ALDH1A1 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.